;PMID: 1617633
;source_file_954.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..38] = [t:0..38]
;1)sentence:[e:44..177] = [t:44..177]
;2)section:[e:181..287] = [t:181..287]
;3)section:[e:291..346] = [t:291..346]
;4)sentence:[e:350..472] = [t:350..472]
;5)sentence:[e:473..600] = [t:473..600]
;6)sentence:[e:601..772] = [t:601..772]
;7)sentence:[e:773..967] = [t:773..967]
;8)sentence:[e:968..1141] = [t:968..1141]
;9)sentence:[e:1142..1426] = [t:1142..1426]
;10)sentence:[e:1427..1550] = [t:1427..1550]
;11)sentence:[e:1551..1731] = [t:1551..1731]
;12)section:[e:1735..1779] = [t:1735..1779]

;section 0 Span:0..38
;Cancer Res. 1992 Jul 1;52(13):3615-21.
(SEC
  (FRAG (NN:[0..6] Cancer) (NNP:[7..10] Res) (.:[10..11] .) (CD:[12..16] 1992)
        (NNP:[17..20] Jul) (CD:[21..26] 1;52-LRB-) (CD:[26..28] 13)
        (-RRB-:[28..29] -RRB-) (CD:[29..34] :3615) (NN:[34..35] -)
        (CD:[35..37] 21) (.:[37..38] .)))

;sentence 1 Span:44..177
;2-Amino-3,4-dimethylimidazo[4,5-f]quinoline induces and inhibits cytochrome
;P450  from the IA subfamily in chick and rat hepatocytes.
;[44..87]:substance:"2-Amino-3,4-dimethylimidazo[4,5-f]quinoline"
;[109..124]:cyp450:"cytochrome P450"
;[135..147]:cyp450:"IA subfamily"
(SENT
  (S-HLN
    (NP-SBJ (NN:[44..87] 2-Amino-3,4-dimethylimidazo-LSB-4,5-f-RSB-quinoline))
    (VP (VBZ:[88..95] induces) (CC:[96..99] and) (VBZ:[100..108] inhibits)
      (NP
        (NP (NN:[109..119] cytochrome) (NN:[120..124] P450))
        (PP (IN:[126..130] from)
          (NP (DT:[131..134] the)
             (NN:[135..137] IA) (NN:[138..147] subfamily))))
      (PP-LOC (IN:[148..150] in)
        (NP
          (NP (NN:[151..156] chick)
            (NML-1 (-NONE-:[156..156] *P*)))
          (CC:[157..160] and)
          (NP (NN:[161..164] rat)
            (NML-1 (NNS:[165..176] hepatocytes))))))
    (.:[176..177] .)))

;section 2 Span:181..287
;Sinclair JF, Schaeffer BK, Wood SG, Lambrecht LK, Gorman N, Bement WJ, Smith
;EL,  Sinclair PR, Waldren CA.
(SEC
  (FRAG (NNP:[181..189] Sinclair) (NNP:[190..192] JF) (,:[192..193] ,)
        (NNP:[194..203] Schaeffer) (NNP:[204..206] BK) (,:[206..207] ,)
        (NNP:[208..212] Wood) (NNP:[213..215] SG) (,:[215..216] ,)
        (NNP:[217..226] Lambrecht) (NNP:[227..229] LK) (,:[229..230] ,)
        (NNP:[231..237] Gorman) (NNP:[238..239] N) (,:[239..240] ,)
        (NNP:[241..247] Bement) (NNP:[248..250] WJ) (,:[250..251] ,)
        (NNP:[252..257] Smith) (NNP:[258..260] EL) (,:[260..261] ,)
        (NNP:[263..271] Sinclair) (NNP:[272..274] PR) (,:[274..275] ,)
        (NNP:[276..283] Waldren) (NNP:[284..287] CA.)))

;section 3 Span:291..346
;VA Medical Center, White River Junction, Vermont 05009.
(SEC
  (FRAG (NNP:[291..293] VA) (NNP:[294..301] Medical) (NNP:[302..308] Center)
        (,:[308..309] ,) (NNP:[310..315] White) (NNP:[316..321] River)
        (NNP:[322..330] Junction) (,:[330..331] ,) (NNP:[332..339] Vermont)
        (.:[340..345] 05009) (.:[345..346] .)))

;sentence 4 Span:350..472
;Several heterocyclic amines, found in cooked food, are powerful mutagens in
;the  Ames Salmonella mutagenicity test system.
;[358..377]:substance:"heterocyclic amines"
;[395..399]:substance:"food"
;[414..422]:substance:"mutagens"
(SENT
  (S
    (NP-SBJ
      (NP (JJ:[350..357] Several)
         (JJ:[358..370] heterocyclic) (NNS:[371..377] amines))
      (,:[377..378] ,)
      (VP (VBN:[379..384] found)
        (NP (-NONE-:[384..384] *))
        (PP-LOC (IN:[385..387] in)
          (NP (VBN:[388..394] cooked) (NN:[395..399] food)))))
    (,:[399..400] ,)
    (VP (VBP:[401..404] are)
      (NP-PRD (JJ:[405..413] powerful) (NNS:[414..422] mutagens))
      (PP (IN:[423..425] in)
        (NP (DT:[426..429] the) (NNP:[431..435] Ames)
            (NNP:[436..446] Salmonella) (NN:[447..459] mutagenicity)
            (NN:[460..464] test) (NN:[465..471] system))))
    (.:[471..472] .)))

;sentence 5 Span:473..600
;One of these,  2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ) is one of
;the most mutagenic  chemicals tested in this assay.
;[488..531]:substance:"2-amino-3,4-dimethylimidazo[4,5-f]quinoline"
;[533..537]:substance:"MeIQ"
;[569..578]:substance:"chemicals"
(SENT
  (S
    (NP-SBJ
      (NP
        (NP (CD:[473..476] One))
        (PP (IN:[477..479] of)
          (NP (DT:[480..485] these))))
      (,:[485..486] ,)
      (NP
        (NP (NN:[488..531] 2-amino-3,4-dimethylimidazo-LSB-4,5-f-RSB-quinoline))
        (NP (-LRB-:[532..533] -LRB-) (NN:[533..537] MeIQ)
            (-RRB-:[537..538] -RRB-))))
    (VP (VBZ:[539..541] is)
      (NP-PRD
        (NP (CD:[542..545] one))
        (PP (IN:[546..548] of)
          (NP
            (NP (DT:[549..552] the) (RBS:[553..557] most)
                (JJ:[558..567] mutagenic) (NNS:[569..578] chemicals))
            (VP (VBN:[579..585] tested)
              (NP (-NONE-:[585..585] *))
              (PP (IN:[586..588] in)
                (NP (DT:[589..593] this) (NN:[594..599] assay))))))))
    (.:[599..600] .)))

;sentence 6 Span:601..772
;In primary cultures of chick and rat  hepatocytes, MeIQ, by itself, induced
;cytochrome P450 from the IA subfamily but  was a weak inducer compared to
;3-methylcholanthrene.
;[652..656]:substance:"MeIQ"
;[677..692]:cyp450:"cytochrome P450"
;[702..714]:cyp450:"IA subfamily"
;[731..738]:substance:"inducer"
;[751..771]:substance:"3-methylcholanthrene"
(SENT
  (S
    (PP-LOC (IN:[601..603] In)
      (NP
        (NP (JJ:[604..611] primary) (NNS:[612..620] cultures))
        (PP (IN:[621..623] of)
          (NP
            (NP (NN:[624..629] chick)
              (NML-1 (-NONE-:[629..629] *P*)))
            (CC:[630..633] and)
            (NP (NN:[634..637] rat)
              (NML-1 (NNS:[639..650] hepatocytes)))))))
    (,:[650..651] ,)
    (NP-SBJ
      (NP (NN:[652..656] MeIQ))
      (,:[656..657] ,)
      (PP (IN:[658..660] by)
        (NP (PRP:[661..667] itself))))
    (,:[667..668] ,)
    (VP
      (VP (VBD:[669..676] induced)
        (NP
          (NP (NN:[677..687] cytochrome) (NN:[688..692] P450))
          (PP (IN:[693..697] from)
            (NP (DT:[698..701] the)
               (NN:[702..704] IA) (NN:[705..714] subfamily)))))
      (CC:[715..718] but)
      (VP (VBD:[720..723] was)
        (NP-PRD
          (NP (DT:[724..725] a) (JJ:[726..730] weak) (NN:[731..738] inducer))
          (VP (VBN:[739..747] compared)
            (NP (-NONE-:[747..747] *))
            (PP-CLR (TO:[748..750] to)
              (NP (NN:[751..771] 3-methylcholanthrene)))))))
    (.:[771..772] .)))

;sentence 7 Span:773..967
;However, in both chick and  rat hepatocytes in culture, MeIQ decreased the
;amount of  3-methylcholanthrene-induced ethoxyresorufin deethylase activity,
;which is  catalyzed by cytochrome P450 IA.
;[829..833]:substance:"MeIQ"
;[859..879]:substance:"3-methylcholanthrene"
;[888..914]:cyp450:"ethoxyresorufin deethylase"
;[948..966]:cyp450:"cytochrome P450 IA"
(SENT
  (S
    (ADVP (RB:[773..780] However))
    (,:[780..781] ,)
    (PP-LOC (IN:[782..784] in)
      (NP
        (NP (CC:[785..789] both)
          (NP (NN:[790..795] chick)
            (NML-2 (-NONE-:[795..795] *P*)))
          (CC:[796..799] and)
          (NP (NN:[801..804] rat)
            (NML-2 (NNS:[805..816] hepatocytes))))
        (PP-LOC (IN:[817..819] in)
          (NP (NN:[820..827] culture)))))
    (,:[827..828] ,)
    (NP-SBJ (NN:[829..833] MeIQ))
    (VP (VBD:[834..843] decreased)
      (NP
        (NP (DT:[844..847] the) (NN:[848..854] amount))
        (PP (IN:[855..857] of)
          (NP
            (NP
              (ADJP (NN:[859..879] 3-methylcholanthrene) (HYPH:[879..880] -)
                    (VBN:[880..887] induced))
              (NML (NN:[888..903] ethoxyresorufin) (NN:[904..914] deethylase))
              (NN:[915..923] activity))
            (,:[923..924] ,)
            (SBAR
              (WHNP-1 (WDT:[925..930] which))
              (S
                (NP-SBJ-1 (-NONE-:[930..930] *T*))
                (VP (VBZ:[931..933] is)
                  (VP (VBN:[935..944] catalyzed)
                    (NP-1 (-NONE-:[944..944] *))
                    (PP (IN:[945..947] by)
                      (NP-LGS (NN:[948..958] cytochrome) (NN:[959..963] P450)
                              (NN:[964..966] IA)))))))))))
    (.:[966..967] .)))

;sentence 8 Span:968..1141
;The protein moiety of cytochrome P450 IA was  decreased at MeIQ
;concentrations of 2.5 micrograms/ml or greater in chick  hepatocytes and 25
;micrograms/ml in rat hepatocytes.
;[972..979]:cyp450:"protein"
;[990..1008]:cyp450:"cytochrome P450 IA"
;[1027..1031]:substance:"MeIQ"
;[1050..1053]:quantitative-value:"2.5"
;[1054..1067]:quantitative-units:"micrograms/ml"
;[1105..1107]:quantitative-value:"25"
;[1108..1121]:quantitative-units:"micrograms/ml"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[968..971] The) (NN:[972..979] protein) (NN:[980..986] moiety))
      (PP (IN:[987..989] of)
        (NP (NN:[990..1000] cytochrome) (NN:[1001..1005] P450)
            (NN:[1006..1008] IA))))
    (VP (VBD:[1009..1012] was)
      (VP (VBN:[1014..1023] decreased)
        (NP-1 (-NONE-:[1023..1023] *))
        (PP (IN:[1024..1026] at)
          (NP
            (NP
              (NP (NN:[1027..1031] MeIQ) (NNS:[1032..1046] concentrations))
              (PP (IN:[1047..1049] of)
                (NP
                  (NP
                    (QP (CD:[1050..1053] 2.5))
                    (NNS:[1054..1064] micrograms))
                  (PP (SYM:[1064..1065] /)
                    (NP (NN:[1065..1067] ml)))
                  (FRAG
                    (QP (CC:[1068..1070] or) (JJR:[1071..1078] greater)))))
              (PP-LOC (IN:[1079..1081] in)
                (NP (NN:[1082..1087] chick) (NNS:[1089..1100] hepatocytes))))
            (CC:[1101..1104] and)
            (NP
              (NP (CD:[1105..1107] 25) (NNS:[1108..1118] micrograms))
              (PP (SYM:[1118..1119] /)
                (NP (NN:[1119..1121] ml)))
              (PP-LOC (IN:[1122..1124] in)
                (NP (NN:[1125..1128] rat) (NNS:[1129..1140] hepatocytes))))))))
    (.:[1140..1141] .)))

;sentence 9 Span:1142..1426
;In hepatic microsomes from  methylcholanthrene-treated chicks and rats, MeIQ
;was a competitive inhibitor of  both ethoxyresorufin deethylase activity, a
;reaction catalyzed mainly by rodent  cytochrome P450 IA1, and
;uroporphyrinogen oxidation, a reaction catalyzed by  rodent P450 IA2.
;[1170..1188]:substance:"methylcholanthrene"
;[1214..1218]:substance:"MeIQ"
;[1237..1246]:substance:"inhibitor"
;[1256..1282]:cyp450:"ethoxyresorufin deethylase"
;[1332..1351]:cyp450:"cytochrome P450 IA1"
;[1357..1373]:substance:"uroporphyrinogen"
;[1417..1425]:cyp450:"P450 IA2"
(SENT
  (S
    (PP-LOC (IN:[1142..1144] In)
      (NP
        (NP (JJ:[1145..1152] hepatic) (NNS:[1153..1163] microsomes))
        (PP (IN:[1164..1168] from)
          (NP
            (NP
              (ADJP-1 (NN:[1170..1188] methylcholanthrene) (HYPH:[1188..1189] -)
                      (VBN:[1189..1196] treated))
              (NNS:[1197..1203] chicks))
            (CC:[1204..1207] and)
            (NP
              (ADJP-1 (-NONE-:[1207..1207] *P*))
              (NNS:[1208..1212] rats))))))
    (,:[1212..1213] ,)
    (NP-SBJ (NN:[1214..1218] MeIQ))
    (VP (VBD:[1219..1222] was)
      (NP-PRD
        (NP (DT:[1223..1224] a) (JJ:[1225..1236] competitive)
            (NN:[1237..1246] inhibitor))
        (PP (IN:[1247..1249] of)
          (NP (CC:[1251..1255] both)
            (NP
              (NP
                (NML (NN:[1256..1271] ethoxyresorufin)
                     (NN:[1272..1282] deethylase))
                (NN:[1283..1291] activity))
              (,:[1291..1292] ,)
              (NP
                (NP (DT:[1293..1294] a) (NN:[1295..1303] reaction))
                (VP (VBN:[1304..1313] catalyzed)
                  (NP (-NONE-:[1313..1313] *))
                  (ADVP (RB:[1314..1320] mainly))
                  (PP (IN:[1321..1323] by)
                    (NP-LGS (NN:[1324..1330] rodent)
                       (NN:[1332..1342] cytochrome) (NN:[1343..1347] P450)
                       (NN:[1348..1351] IA1))))))
            (,:[1351..1352] ,) (CC:[1353..1356] and)
            (NP
              (NP (NN:[1357..1373] uroporphyrinogen) (NN:[1374..1383] oxidation))
              (,:[1383..1384] ,)
              (NP
                (NP (DT:[1385..1386] a) (NN:[1387..1395] reaction))
                (VP (VBN:[1396..1405] catalyzed)
                  (NP (-NONE-:[1405..1405] *))
                  (PP (IN:[1406..1408] by)
                    (NP-LGS (NN:[1410..1416] rodent)
                       (NN:[1417..1421] P450) (NN:[1422..1425] IA2))))))))))
    (.:[1425..1426] .)))

;sentence 10 Span:1427..1550
;In cultured chick hepatocytes, MeIQ also decreased cytochrome  P450-mediated
;oxidation of uroporphyrinogen by intact cells.
;[1458..1462]:substance:"MeIQ"
;[1478..1494]:cyp450:"cytochrome  P450"
;[1517..1533]:substance:"uroporphyrinogen"
(SENT
  (S
    (PP-LOC (IN:[1427..1429] In)
      (NP (VBN:[1430..1438] cultured) (NN:[1439..1444] chick)
          (NNS:[1445..1456] hepatocytes)))
    (,:[1456..1457] ,)
    (NP-SBJ (NN:[1458..1462] MeIQ))
    (ADVP (RB:[1463..1467] also))
    (VP (VBD:[1468..1477] decreased)
      (NP
        (NP
          (ADJP
            (NML (NN:[1478..1488] cytochrome) (NN:[1490..1494] P450))
            (HYPH:[1494..1495] -) (VBN:[1495..1503] mediated))
          (NN:[1504..1513] oxidation))
        (PP (IN:[1514..1516] of)
          (NP (NN:[1517..1533] uroporphyrinogen)))
        (PP (IN:[1534..1536] by)
          (NP (JJ:[1537..1543] intact) (NNS:[1544..1549] cells)))))
    (.:[1549..1550] .)))

;sentence 11 Span:1551..1731
;The ability of MeIQ  to inhibit as well as to induce cytochrome P450s of the
;IA subfamily may be  important in assessing the mutagenic and carcinogenic
;effects of MeIQ in  mammals.
;[1566..1570]:substance:"MeIQ"
;[1604..1620]:cyp450:"cytochrome P450s"
;[1628..1640]:cyp450:"IA subfamily"
;[1714..1718]:substance:"MeIQ"
(SENT
  (S
    (NP-SBJ
      (NP (DT:[1551..1554] The) (NN:[1555..1562] ability)
        (S-2 (-NONE-:[1562..1562] *ICH*)))
      (PP (IN:[1563..1565] of)
        (NP (NN:[1566..1570] MeIQ)))
      (S-2
        (NP-SBJ (-NONE-:[1570..1570] *))
        (VP
          (VP (TO:[1572..1574] to)
            (VP (VB:[1575..1582] inhibit)
              (NP-3 (-NONE-:[1582..1582] *RNR*))))
          (CONJP (RB:[1583..1585] as) (RB:[1586..1590] well)
                 (IN:[1591..1593] as))
          (VP (TO:[1594..1596] to)
            (VP (VB:[1597..1603] induce)
              (NP-3 (-NONE-:[1603..1603] *RNR*))))
          (NP-3
            (NP (NN:[1604..1614] cytochrome) (NNS:[1615..1620] P450s))
            (PP (IN:[1621..1623] of)
              (NP (DT:[1624..1627] the)
                 (NN:[1628..1630] IA) (NN:[1631..1640] subfamily)))))))
    (VP (MD:[1641..1644] may)
      (VP (VB:[1645..1647] be)
        (ADJP-PRD (JJ:[1649..1658] important))
        (PP (IN:[1659..1661] in)
          (S-NOM
            (NP-SBJ (-NONE-:[1661..1661] *))
            (VP (VBG:[1662..1671] assessing)
              (NP
                (NP (DT:[1672..1675] the)
                  (NML
                    (NML (JJ:[1676..1685] mutagenic)
                      (NML-1 (-NONE-:[1685..1685] *P*)))
                    (CC:[1686..1689] and)
                    (NML (JJ:[1690..1702] carcinogenic)
                      (NML-1 (NNS:[1703..1710] effects)))))
                (PP (IN:[1711..1713] of)
                  (NP (NN:[1714..1718] MeIQ))))
              (PP-LOC (IN:[1719..1721] in)
                (NP (NNS:[1723..1730] mammals))))))))
    (.:[1730..1731] .)))

;section 12 Span:1735..1779
;PMID: 1617633 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[1735..1739] PMID) (::[1739..1740] :) (CD:[1741..1748] 1617633)
        (IN:[1749..1750] -LSB-) (NNP:[1750..1756] PubMed) (HYPH:[1757..1758] -)
        (JJ:[1759..1766] indexed) (IN:[1767..1770] for)
        (NNP:[1771..1779] MEDLINE-RSB-)))
